For years, India’s medical tourism narrative has been framed around one variable: affordability. While competitive pricing helped the sector gain global visibility, it no longer explains why it today attracts one of the world’s largest and most diverse pools of international patients.
Beyond just cheaper care, the new drivers are clinical outcomes, technological depth and institutional reliability. But if we continue to position the country as the world’s “low-cost hospital”, we risk undermining one of our most credible healthcare strengths.
The Indian medical tourism industry touched nearly $7.69 billion in 2024, with the arrival of 7.3 million foreign patients. In the first four months of 2025 alone, over 131,000 visiting foreign patients accounted for more than four per cent of total tourist arrivals. There is a growing share of high-acuity, life-impacting cases, including complex cardiac surgeries, advanced oncology, neurosurgical interventions, transplant-linked pathways and robotic-assisted procedures. These are choices driven by survival probabilities and confidence in clinical governance, not affordability alone.
This shift is especially evident in India’s neighbourhood, with proximity, access and cultural familiarity continuing to influence patient flows from SAARC countries, West Asia and Africa.
In the Maldives, where tertiary care systems are still evolving, patients routinely travel abroad for high-acuity treatment. Referrals under the government-funded Aasandha healthcare scheme increasingly point towards cardiovascular care, oncology and critical-care services in India. These decisions are driven not by cost arbitrage but trust in clinical outcomes, multidisciplinary expertise and institutional depth.
Sustainability
However, leadership in cross-border care cannot rest on reputation alone. India’s regulatory and governance frameworks must keep pace. Uniform outcome reporting, transparent pricing structures and stronger infection-control standards are essential to sustain global credibility. The institutions that will define India’s next decade of healthcare leadership are those that embed measurable protocols, multidisciplinary reviews and transparent benchmarks into daily practice.
Equally important is continuity of care. A cardiac procedure in Bengaluru or an oncology cycle in Delhi is only as effective as the support a patient receives months later in Malé, Addis Ababa or Yangon. Strengthening telemedicine follow-ups, interoperable medical records and clinician-to-clinician referral pathways will convert episodic treatment into long-term trust.
India’s advantage lies in the convergence of scale, skill and regional trust. The real question is not whether India can lead, but whether it is ready to define a bolder narrative and meet the standards that true healthcare leadership demands.
(The writer is Group Chief Operating Officer, Manipal Hospitals)
More Like This
Published on December 29, 2025